bioRxiv Science⌕ Search

Biology subjects

Shibata, D.

Publications and source records attributed to Shibata, D..

At least 19 recordsLinked to original sources

Annotation-Based Gene-Peak Links Improve Regulatory Network Prediction of Gene Expression in Human Kidney Multi-Omics

BackgroundLinking distal regulatory elements to their target genes is a central problem for interpreting chromatin accessibility and other non-coding genomic data. Proximity-based mapping is convenient but ignores three-dimensional enhancer-promoter architecture and can misassign long-range regulatory effects. Correlation-based approaches can also miss regulatory links because of limited statistical power and restrictive distance or significance thresholds. Single-cell and single-nucleus multi-omic datasets, such as 10x Multiome profiles that jointly measure chromatin accessibility and gene expression in the same cells or nuclei, now provide a way to evaluate gene-peak linkage strategies by testing how well linked accessibility features predict gene expression. Existing methods often focus on scoring individual enhancer-gene pairs. In this study, we proposed and constructed a fast annotation-based candidate gene-peak network and tested whether it improves downstream prediction of gene expression. MethodsWe first built a unified gene-peak regulatory network by integrating enhancer-based, promoter-based, and proximity-based linkage strategies. We then used single-cell multiome data from the Kidney Precision Medicine Project (KPMP) 10x Multiome cohort to evaluate whether the proposed links captured regulatory signals. We aggregated RNA expression and ATAC accessibility at the cell-type cluster level and trained predictive models to evaluate how well different linkage strategies could explain gene expression based on accessibility. Model performance was compared between annotation-based (including both enhancer- and promoter-based links) and proximity-based gene-peak links using testing R{superscript 2} and mean squared error (MSE) in a strict set of 1,704 genes and an adaptive set of 7,973 genes with more relaxed requirements. ResultsIn the strict regime (1,704 genes with [≥]20 peaks assigned by the nearest-TSS rule and [≥]10 annotated enhancer-based peaks), the annotation-based model consistently achieved higher testing R{superscript 2} and lower testing MSE than the proximity-based model. In the larger adaptive regime (7,973 genes with [≥]5 proximity-based and [≥]2 enhancer-based peaks), we defined for each gene a balanced number of selected peaks based on its available closest and enhancer links; the annotation-based model again showed globally higher testing R{superscript 2} and lower testing MSE. These improvements were observed over a broad range of candidate-linked peak numbers. ConclusionsUsing human kidney 10x Multiome data, we show that a fast annotation-based gene-peak linkage framework can improve prediction of gene expression from chromatin accessibility compared with conventional approaches. These results support the use of biologically informed enhancer and promoter annotations when constructing candidate gene regulatory networks. Our framework also showed concordance with the correlation-based Signac LinkPeaks method while providing broader coverage and greater computational efficiency. We have implemented these annotation-based linkage methods in the GPlinksR R package, providing a fast and scalable tool for constructing regulatory networks.

genomics↗

Fluctuating DNA methylation sites encode colorectal tumour growth history

Determining the nature of human tumour growth is challenging given the impracticality of obtaining detailed data across time. A promising solution is to examine DNA regions whose methylation states fluctuate on clinically relevant timescales, permitting their use as high-resolution lineage tracers. However, existing methods developed for analysing the fluctuating methylation loci of normal tissue and lymphoid cancers are inapplicable to large solid tumours. Here we introduce a mechanistic computational model that tracks the evolution of heritable methylation marks as a tumour grows from a single gland to a mass of many cubic centimetres, and a coupled ABC-SMC inference workflow to estimate tumour growth parameters from multi-region bulk methylation arrays. We applied this framework to data from multiple regions of 10 resected colorectal tumours, including 3 adenomas and 7 carcinomas of diverse sizes and clinical stages. By exploring alternative models, we show that intratumour diversity, in terms of methylation errors, stems more from tumour growth via gland fission than from cell turnover within glands. Moreover, the extent of intratumour diversity varies widely between patients, mainly because of eight-fold variation in gland fission rates but also due to differences in methylation and demethylation rates. Inter-gland divergence patterns are consistent with neutral evolution of colorectal tumours and a cancer stem cell fraction of approximately 1%. As well as helping to resolve the nature of colorectal cancer growth and evolution, our results provide proof of principle for a method that may be adapted to infer the biological parameters of other types of solid tumour. Author summaryEstimating how fast, for how long, and in what way a tumour has been growing inside someones body is challenging. We sought a solution by looking at chemical marks on DNA that are imperfectly copied every time a cell divides. We built a computer model to track how the patterns of marks diverge among the cells of a colorectal tumour as it grows. By running many simulations and comparing the outcomes to data from 10 human tumours, we were able to reconstruct how each of them had grown. We found that growth rate varies widely and is not linked to the size of the tumour when it is removed. The rates at which the DNA marks change also vary but to a lesser degree. Our approach provides a new, inexpensive way to reconstruct tumour growth histories from tissue samples collected during routine surgery, without having to take multiple measurements over time. This approach could be applied to other human cancer types.

cancer biology↗

Production of cellobiose from ionic liquid-treated cellulose using the highly thermostable cellobiohydrolase HmCel6A-3SNP at 80°C and analysis of enzymatic accessibility to the substrate

Cellobiose is an important disaccharide used in food, health, and biorefinery applications, but its efficient enzymatic production from crystalline cellulose remains challenging. In this study, crystalline cellulose was dissolved in ionic liquids and regenerated by dilution, and subsequently hydrolyzed at 80{degrees}C using a highly thermostable cellobiohydrolase, HmCel6A-3SNP. The enzyme retained activity in the presence of low concentrations of ionic liquids. Among the pretreatment conditions tested, cellulose treated with 1-butyl-3-methylimidazolium chloride ([Bmim]Cl) showed the highest enzymatic digestibility. After washing to remove residual ionic liquid, the reaction produced reducing sugars at levels 1.5-fold higher than those obtained in the presence of 10% [Bmim]Cl, with cellobiose accounting for approximately 96% of the products. Under the optimized conditions, the hydrolysis yield reached [~]36% after 48 hr. Structural analyses using birefringence imaging, electron microscopy, and Fourier transform infrared spectroscopy indicated that higher-order structural changes in regenerated cellulose strongly influence enzymatic accessibility. These results demonstrate the potential of combining ionic-liquid pretreatment with thermostable enzymes for selective cellobiose production from cellulose.

biochemistry↗

PHYFUM: Phylogenetic Reconstruction of Normal and Pre-malignant Tissue Evolution Using Fluctuating Methylation

We present PHYFUM, a novel Bayesian phylogenetic method for methylation data that reconstructs the evolutionary history of stem cells and the glandular structures they reside within in normal tissue. Using simulations, we validated this phylogenetic method and confirmed its accuracy. A re-analysis of 22 patients unveiled early gland divergence in the human gut, in contrast to a much later common ancestor in the endometrium, and yielded strong evidence against gland division by segregation of individual stem cells.

bioinformatics↗

Metabolic specialization structures gut bacterial niches and drives colorectal cancer progression

Despite the established association between the gut microbiome and colorectal cancer (CRC), the functional distinction between microbial passengers and drivers of CRC progression remains unresolved. Here, we collected stool, blood, as well as paired tumor, and normal mucosa tissues from seventy-seven CRC patients to characterize the systemic and localized impact of the gut microbiome on early- and late-stage CRC. By deep shotgun metagenomic sequencing, we identified distinct bacterial species and functions residing in tumor versus normal mucosa, highlighting an enrichment of oral-associated bacteria in tumor tissues. Several of these species remained undetected in the stool microbiome analysis. We further combined bacterial culturing with untargeted metabolomics of bacteria enriched in tumor and normal mucosa tissues, revealing distinct clusters of metabolic potential. Functional testing of multiple members from one cluster comprising both tumor- and mucosa-enriched species revealed Leptotrichia wadei as a pro-tumorigenic bacterium in a murine CRC model. Single-nucleus RNA sequencing and in vitro experiments further demonstrated that L. wadei and its secretome induces M2 macrophage polarization to promote tumor growth. Overall, our study shows that metabolic specialization structures microbial colonization niches, while species-specific metabolic outputs identify functional drivers of CRC progression, and uncovers L. wadei as an oncogenic bacterium in CRC.

microbiology↗

Aggressive Neuroblastomas Start Growing after Infancy

In neuroblastoma, population screening during infancy failed to lower mortality because it primarily detected biologically indolent tumors rather than aggressive, life-threatening disease. The failure may reflect limited screening sensitivity, or disease onset after infancy among aggressive tumors. Here, we used an epigenetic mitotic clock based on fluctuating CpG DNA methylation to estimate patient-specific tumor mitotic ages and calendar ages in a cohort of unscreened children diagnosed with neuroblastoma. Aggressive cancers (stage 4) primarily started growing after the first year of life, making them undetectable by screening during infancy. In contrast, biologically more indolent tumors (stages 1, 2, 3 and 4S) often started growing in utero or during the first year of life, and affected children had better survival outcomes. Due to a short preclinical detectable phase of aggressive neuroblastomas, reducing mortality through screening is impractical as it would require frequent screening among older children. Patient-specific tumor-age estimation may help refine screening windows and improve early-detection strategies in other cancers where screening has so far failed to yield substantial mortality reductions.

cancer biology↗

Oxylipin carbonyl compositions in the chloroplast compartments

Aldehydes and ketones derived from oxidized lipids (oxylipin carbonyls) accumulate in plants under stress conditions, acting as signaling molecules or cytotoxic agents through electrophilic modification of biomolecules. Because chloroplasts generate reactive oxygen species and contain lipids rich in unsaturated fatty acids, they are likely major sites of oxylipin carbonyl formation. To identify chloroplast-derived carbonyl species and their sub-organellar distribution, we analyzed carbonyls in spinach leaves, whole chloroplasts, thylakoids, envelopes and stroma. A total of 26 carbonyl species were detected, of which 13 were identified. Chloroplasts contained 14 species, including formaldehyde, propionaldehyde, acetaldehyde, acetone, butyraldehyde, (E)-2-pentenal, (Z)-3-hexenal, (E)-2-hexenal, n-hexanal and 4-hydroxy-(E)-2-hexenal. Phenylacetaldehyde and n-pentanal, which were abundant in leaves, were not associated with chloroplasts. Thylakoid membranes contained all chloroplast carbonyls except acetone, indicating that they are a major site of carbonyl formation. Formaldehyde was highly enriched in thylakoids and envelopes, providing evidence that it can be generated within chloroplasts, most likely from membrane lipids. Estimated concentrations of several carbonyls in membranes reached over 1 millimolar. This high-resolution mapping of oxylipin carbonyls within chloroplast compartments, achieved here for the first time, provides a spatial framework for understanding their formation and functional roles in plant stress responses.

plant biology↗

Searching for Acrolein-Scavenging Compounds in Plants: Isoalliin from Onion as an Excellent Scavenger

Reactive carbonyl species (RCS), such as acrolein (Acr), are generated through the degradation of lipid peroxides and exert cytotoxic effects. To identify natural RCS scavengers, we examined 80% ethanol extracts from 46 angiosperm species for Acr-trapping activity using an HPLC-based assay. Strong activities were observed in several taxa, including garlic, spinach, avocado, broccoli, and lotus. In garlic, the active metabolite was identified as S-allyl-L-cysteine sulfoxide (alliin), a characteristic Allium amino acid. Alliin and its S-(1E)-propenyl and S-methyl derivatives (isoalliin and methiin, respectively) trapped up to two Acr molecules at the amino group and exhibited higher activities than known scavengers such as carnosine and epigallocatechin gallate. These findings highlight S-alk(en)yl-L-cysteine sulfoxides as potent secondary antioxidants and suggest that structurally diverse RCS scavengers remain to be discovered in plants.

plant biology↗

CRISPR/Cas9-mediated genome editing reveals the involvement of a polyphenol oxidase in the shikonin-specific biosynthesis in Lithospermum erythrorhizon

Shikonin, a 1,4-naphthoquinone derivative produced by several Boraginaceae species, exhibits unique pharmacological properties and is used as a natural dye. The regulatory factors of shikonin production have been demonstrated using a cell culture system of Lithospermum erythrorhizon. Among these factors, copper is known to be the strongest enhancer of shikonin production. Although shikonin biosynthesis has been studied for over 40 years, the steps of naphthalene ring formation are still unknown, as is the reason for the effect of copper. In this study, we explored candidate genes associated with shikonin production using a PCR-select subtraction experiment. Polyphenol oxidase (PPO), a dicopper-dependent oxidoreductase, was highlighted because it showed synchronous expression with shikonin production. Transcriptome analysis of hairy roots and cultured cells of this plant revealed that, of the five PPO genes expressed in L. erythrorhizon, only PPO1 showed a strong correlation with shikonin production. Next, we generated genome-edited hairy roots of LePPO1 using CRISPR/Cas9-mediated mutagenesis to analyze its impact on shikonin derivative and other specialized metabolite production. The results showed that shikonin content was markedly reduced in all LePPO1-ge lines. Interestingly, the content of deoxyshikonofuran, a hydroquinone derivative and shunt product that branches after GHQ-3''-OH in the shikonin biosynthetic pathway, remained unaffected in the LePPO1-ge lines. These findings suggest that LePPO1 participates in naphthalene ring formation and explain why a copper ion is crucial for shikonin biosynthesis.

biochemistry↗

Obesity promotes conserved inflammatory and metabolic transcriptional programs in mouse and human colon tumors

BackgroundThe global prevalence of obesity, an established risk and progression factor for colon cancer, is high and rising. Unfortunately, the mechanisms underlying the obesity-colon cancer association are incompletely understood, and new molecular targets enabling more effective intervention strategies to break the obesity-colon cancer link are urgently needed. ObjectiveThis study integrated RNA sequencing data from mouse and human colon tumor samples, as well as human adipose samples, to rigorously establish obesity-associated transcriptomic signatures conserved between the two species. MethodsWe employed a mouse colon cancer model with colonoscopy-guided orthotopic transplantation of syngeneic Apc-null;KrasG12D/+;Trp53-null;Smad4-null;tdTomato colon tumor organoids. Epithelial cell adhesion molecule (EpCAM)-positive cells from murine tumors, and 193 human colon tumors and 188 human mesenteric adipose tissue samples from the ColoCare cohort underwent transcriptomic analyses. ResultsDiet-induced obesity reduced survival in the mouse model of colon cancer. Integrated transcriptomic analyses of EpCAM-positive murine tumor cells and bulk human tumors revealed obesity-driven enrichment of inflammation and metabolic pathways, including upregulation of genes involved in innate immune sensing (TLR2, MYD88, IRF4) and tumor microenvironment remodeling (MMP9, TGFB1, SERPINE1). Analysis of paired mesenteric visceral adipose tissue and tumor samples from the ColoCare cohort indicated that obesity amplifies inflammatory signaling pathways through unique adipose ligand-tumor receptor interactions. ConclusionsThese results establish obesity-associated adipose tissue dysregulation as a key inter-tissue modulator of biology, with concordant cross-species effects on tumor cell-intrinsic inflammatory and metabolic programs.

cancer biology↗

Mapping the Temporal Landscape of Breast Cancer Using Epigenetic Entropy

Although generally unknown, the age of a newly diagnosed tumor encodes valuable etiologic and prognostic information. Here, we estimate the age of breast cancers, defined as the time from the start of growth to detection, using a measure of epigenetic entropy derived from genome-wide methylation arrays. Based on an ensemble of neutrally fluctuating CpG (fCpG) sites, this stochastic epigenetic clock differs from conventional clocks that measure age-related increases in methylation. We show that younger tumors exhibit hallmarks of aggressiveness, such as increased proliferation and genomic instability, whereas older tumors are characterized by elevated immune infiltration, indicative of enhanced immune surveillance. These findings suggest that the clock captures a tumors effective growth rate resulting from the evolutionary-ecological competition between intrinsic growth potential and external systemic pressures. Because of the clocks ability to delineate old and stable from young and aggressive tumors, it has potential applications in risk stratification of early-stage breast cancers and guiding early detection efforts.

cancer biology↗

Human Brain Barcodes

Dynamic CpG methylation "barcodes" were read from 15,000 to 21,000 single cells from three human male brains. To overcome sparse sequencing coverage, the barcode had [~]31,000 rapidly fluctuating X-chromosome CpG sites (fCpGs), with at least 500 covered sites per cell and at least 30 common sites between cell pairs (average of [~]48). Barcodes appear to start methylated and record mitotic ages because excitatory neurons and glial cells that emerge later in development were less methylated. Barcodes are different between most cells, with average pairwise differences (PWDs) of [~]0.5 between cells. About 10 cell pairs per million were more closely related with PWDs < 0.05. Barcodes appear to record ancestry and reconstruct trees where more related cells had similar phenotypes, albeit some pairs had phenotypic differences. Inhibitory neurons showed more evidence of tangential migration than excitatory neurons, with related cells in different cortical regions. fCpG barcodes become polymorphic during development and can distinguish between thousands of human cells.

neuroscience↗

Developmental hematopoietic stem cell variation explains clonal hematopoiesis later in life

Clonal hematopoiesis becomes increasingly common with age, but its cause is enigmatic because driver mutations are often absent. Serial observations infer weak selection indicating variants are acquired much earlier in life with unexplained initial growth spurts. Here we use fluctuating CpG methylation as a lineage marker to track stem cell clonal dynamics of hematopoiesis. We show, via the shared prenatal circulation of monozygotic twins, that weak selection conferred by stem cell variation created before birth can reliably yield clonal hematopoiesis later in life. Theory indicates weak selection will lead to dominance given enough time and large enough population sizes. Human hematopoiesis satisfies both these conditions. Stochastic loss of weakly selected variants is naturally prevented by the expansion of stem cell lineages during development. The dominance of stem cell clones created before birth is supported by blood fluctuating CpG methylation patterns that exhibit low correlation between unrelated individuals but are highly correlated between many elderly monozygotic twins. Therefore, clonal hematopoiesis driven by weak selection in later life appears to reflect variation created before birth.

systems biology↗

Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development

Ductal carcinoma in situ (DCIS) and invasive breast cancer share many morphologic, proteomic, and genomic alterations. Yet in contrast to invasive cancer, many DCIS tumors do not progress and may remain indolent over decades. To better understand the heterogenous nature of this disease, we reconstructed the growth dynamics of 18 DCIS tumors based on the geo-spatial distribution of their somatic mutations. The somatic mutation topographies revealed that DCIS is multiclonal and consists of spatially discontinuous subclonal lesions. Here we show that this pattern of spread is consistent with a new Comet model of DCIS tumorigenesis, whereby multiple subclones arise early and nucleate the buds of the growing tumor. The discontinuous, multiclonal growth of the Comet model is analogous to the branching morphogenesis of normal breast development that governs the rapid expansion of the mammary epithelium during puberty. The branching morphogenesis-like dynamics of the proposed Comet model diverges from the canonical model of clonal evolution, and better explains observed genomic spatial data. Importantly, the Comet model allows for the clinically relevant scenario of extensive DCIS spread, without being subjected to the selective pressures of subclone competition that promote the emergence of increasingly invasive phenotypes. As such, the normal cell movement inferred during DCIS growth provides a new explanation for the limited risk of progression in DCIS and adds biologic rationale for ongoing clinical efforts to reduce DCIS overtreatment.

cancer biology↗

Testing Adaptive Therapy Protocols using Gemcitabine and Capecitabine on a Mouse Model of Endocrine-Resistant Breast Cancer

Highly effective cancer therapies often face limitations due to acquired resistance and toxicity. Adaptive therapy, an ecologically inspired approach, seeks to control therapeutic resistance and minimize toxicity by leveraging competitive interactions between drug-sensitive and drug-resistant subclones, prioritizing patient survival and quality of life over maximum cell kill. In preparation for a clinical trial in breast cancer, we used large populations of MCF7 cells to rapidly generate endocrine-resistance breast cancer cell line. We then mimicked second line therapy in ER+ breast cancers by treating the endocrine-resistant MCF7 cells in a mouse xenograft model to test adaptive therapy with capecitabine, gemcitabine, or the combination of those two drugs. Dose-modulation adaptive therapy with capecitabine alone increased survival time relative to MTD, but not statistically significant (HR: 0.22, 95% CI 0.043-1.1 P = 0.065). However, when we alternated the drugs in both dose modulation (HR = 0.11, 95% CI: 0.024 - 0.55, P = 0.007) and intermittent adaptive therapies significantly increased survival time compared to high dose combination therapy (HR = 0.07, 95% CI: 0.013 - 0.42; P = 0.003). Overall, survival time increased with reduced dose for both single drugs (P < 0.01) and combined drugs (P < 0.001). Adaptive therapy protocols resulted in tumors with lower proportions of proliferating cells (P = 0.0026) and more apoptotic cells (P = 0.045). The results show that Adaptive therapy outperforms high-dose therapy in controlling endocrine-resistant breast cancer, favoring slower-growing tumors, and showing promise in two-drug alternating regimens.

cancer biology↗

Gattaca: Base pair resolution mutation tracking for somatic evolution studies using agent-based models

Gattaca provides the first base-pair resolution artificial genomes for tracking somatic mutations within agent based modeling. Through the incorporation of human reference genomes, mutational context, sequence coverage/error information Gattaca is able to realistically provide comparable sequence data for in-silico comparative evolution studies with human somatic evolution studies. This user-friendly method, incorporated into each in-silico cell, allows us to fully capture somatic mutation spectra and evolution.

evolutionary biology↗

Phenotypic plasticity and genetic control in colorectal cancer evolution

Cancer evolution is driven by natural selection acting upon phenotypic trait variation. However, the extent to which phenotypic variation within a tumour is a consequence of intra-tumour genetic heterogeneity remains undetermined. Here we show that colorectal cancer cells frequently have highly plastic phenotypic traits in vivo in patient tumours. We measured the degree to which trait variation reflects genetic ancestry by quantifying the phylogenetic signal of gene expression across 297 samples with multi-region paired whole genome and transcriptome sequencing collected from 27 primary colorectal cancers. Within-tumour phylogenetic signal for genes and pathways was detected only infrequently, suggesting that the majority of intra-tumour variation in gene expression programmes was not strongly heritable. Expression quantitative trait loci analyses (eQTL) identified a small number of putative mechanisms of genetic control of gene expression due to the cis-acting coding, non-coding and structural genetic alteration, but most gene expression variation was not explained by our genetic analysis. Leveraging matched chromatin-accessibility sequencing data, enhancer mutations with cis regulatory effects on gene expression were associated with a change in chromatin accessibility, indicating that non-coding variation can have phenotypic consequence through modulation of the 3D architecture of the genome. This study maps the evolution of transcriptional variation during cancer evolution, highlighting that intra-tumour phenotypic plasticity is pervasive in colorectal malignancies, and may play key roles in further tumour evolution, from metastasis to therapy resistance.

cancer biology↗

Assessment of the evolutionary consequence of putative driver mutations in colorectal cancer with spatial multiomic data

Cancer genomic medicine relies on targeting driver genes. However, current catalogues of cancer drivers are mostly based on indirect measurements of mutation frequencies, positions or types, rather than their effect on clonal expansions in vivo. Moreover, non-genetic drivers are largely unknown, as are the epigenetic and transcriptomic effects of genetic drivers. Here we perform spatial computational inference on multiomic data with matched whole-genome sequencing, ATAC-seq and RNA-seq. Using 436 samples, we directly quantify the contribution, or lack thereof, of putative driver genes to subclonal expansions in vivo in 30 colorectal carcinomas (4-33 samples per patient, median=15). Although subclonal neutral evolution was widespread (13/26 cases with sufficient data), there were cases with clear evidence of subclonal selection (6/26) in which we measured epigenetic and transcriptomic differences between subclones in vivo. In 7/26 cases we could not distinguish between neutral or selective evolution with the available data. We identified expanding subclones that were not driven by known genetic alterations, and propose candidate epigenetic drivers. We identified the distinguishing patterns of genomic heterogeneity produced in fast, exponentially growing tumours (7/26) versus neoplasms growing only at the periphery (19/26), as well as identifying clonally intermixed (16/28 cases with sufficient data) versus segregated malignancies (10/28). Our model-based approach measures genetic and non-genetic subclonal selection, or lack thereof, in space and time and allows in vivo comparisons of the emergent phenotypic properties of subclones within human tumours.

cancer biology↗